CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $342,218 | -33.5% | 58,599 | -23.7% | 0.27% | -37.9% |
| Q3 2022 | $515,000 | +60.4% | 76,801 | +0.6% | 0.43% | +58.0% |
| Q2 2022 | $321,000 | +23.9% | 76,354 | -0.5% | 0.27% | +60.2% |
| Q1 2022 | $259,000 | -3.7% | 76,749 | -10.2% | 0.17% | +8.9% |
| Q4 2021 | $269,000 | -24.4% | 85,483 | +1.3% | 0.16% | -35.7% |
| Q2 2021 | $356,000 | -13.4% | 84,368 | +2.4% | 0.24% | -21.0% |
| Q1 2021 | $411,000 | -57.0% | 82,402 | +9.1% | 0.31% | -60.8% |
| Q4 2020 | $955,000 | – | 75,533 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |